Sai Life Sciences Limited — Others, 16-05-2025: Copy of Newspaper Publication

Sai Life Sciences Limited has announced a postal ballot with remote e-voting to approve extending ESOP Schemes 2008 and 2018 benefits to employees of subsidiaries and group companies. It also plans to appoint Dr. Dinesh V Patel as Independent Director and Mr. Sivaramakrishnan Chittor as Whole-Time Director. The company reported total income from operations at ₹1016.86 Cr (standalone) and ₹1098.81 Cr (consolidated), with net profit after tax of ₹264.05 Cr and ₹257.85 Cr, respectively. Earnings per share stand at ₹1.27 (standalone) and ₹1.23 (consolidated). Share capital rose to ₹208.12 Cr after demerger and share allotment from ITC Limited, ending its subsidiary status as of January 2025.